Company / Cost of Revenue
EXACT SCIENCES CORP Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$984.2M
FY2025
5-year range
$458.8M / $984.2M
FY2021-FY2025
Trend
+17.1%
vs FY2024
Sector context
#45 of 107
Health Care
What the data says
At $984M, EXACT SCIENCES CORP's cost of revenue ranks #63 of 107 in the Health Care sector. Cost of Revenue has increased for 7 consecutive years, from $7M in FY2018 to $984M in FY2025.
Based on SEC 10-K filings.
$984M in FY2025 with a 5-year CAGR of +22.7%.
Increased from $738M to $984M over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- +22.7%
- 10-Year CAGR
- -
Sector benchmark
#63 of 107 in Health CareTop 58% of 107This company $984.2M Sector average $11.8B
▼
-91.6% below sector average
Key checks
Key Insights
- EXACT SCIENCES CORP's cost of revenue has grown for 7 consecutive years.
- 5-year CAGR of +22.7%, indicating consistent growth.
- In FY2025, cost of revenue increased 17.1% year-over-year.
- Ranks #45 out of 107 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $984.2M | +17.1% |
| FY2024 | $840.1M | +13.9% |
| FY2023 | $737.6M | +11.5% |
| FY2022 | $661.4M | +44.2% |
| FY2021 | $458.8M | +29.5% |
| FY2020 | $354.3M | +63.5% |
| FY2019 | $216.7M | +2868.7% |
| FY2018 | $7.3M | -90.7% |
| FY2017 | $78.3M | +73.3% |
| FY2016 | $45.2M | +84.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026